nad has been researched along with Diabetic Angiopathies in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Borkowska, A; Cypryk, K; Gebicki, J; Katarzynska, J; Los, A; Marcinek, A | 1 |
| Ido, Y | 1 |
| Asahina, T; Harada, N; Ikebuchi, M; Kashiwagi, A; Kikkawa, R; Nishio, Y; Saeki, Y; Shigeta, Y; Takagi, Y; Tanaka, Y | 1 |
| Ido, Y; Kilo, C; Williamson, JR | 2 |
| Arrigoni-Martelli, E; Williamson, JR | 1 |
| Chang, K; Easom, RA; Sherman, WR; Turk, J; Williamson, JR; Wolf, BA | 1 |
| Clements, RS; Morrison, AD; Winegrad, AI | 1 |
3 review(s) available for nad and Diabetic Angiopathies
| Article | Year |
|---|---|
Diabetic complications within the context of aging: Nicotinamide adenine dinucleotide redox, insulin C-peptide, sirtuin 1-liver kinase B1-adenosine monophosphate-activated protein kinase positive feedback and forkhead box O3.
Topics: Aging; AMP-Activated Protein Kinases; Animals; C-Peptide; Diabetes Complications; Diabetic Angiopathies; Disease Models, Animal; Epigenesis, Genetic; Feedback, Physiological; Forkhead Box Protein O3; Humans; Hypoxia; Insulin Resistance; NAD; Oxidation-Reduction; Oxidative Stress; Signal Transduction; Sirtuin 1 | 2016 |
Cytosolic NADH/NAD+, free radicals, and vascular dysfunction in early diabetes mellitus.
Topics: Animals; Cytosol; Diabetic Angiopathies; Free Radicals; Humans; NAD; Oxidation-Reduction | 1997 |
The roles of glucose-induced metabolic hypoxia and imbalances in carnitine metabolism in mediating diabetes-induced vascular dysfunction.
Topics: Animals; Blood Glucose; Carnitine; Cell Hypoxia; Diabetic Angiopathies; Humans; NAD | 1992 |
5 other study(ies) available for nad and Diabetic Angiopathies
| Article | Year |
|---|---|
Flow-Mediated Skin Fluorescence (FMSF) Technique for Studying Vascular Complications in Type 2 Diabetes.
Topics: Aged; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Forearm; Humans; Luminescent Measurements; Male; Microcirculation; Middle Aged; NAD; Predictive Value of Tests; Regional Blood Flow; Skin | 2020 |
Impaired activation of glucose oxidation and NADPH supply in human endothelial cells exposed to H2O2 in high-glucose medium.
Topics: Adenosine Triphosphate; Cells, Cultured; Culture Media; Diabetic Angiopathies; Endothelium, Vascular; Glucose; Glucose-6-Phosphate; Glucosephosphate Dehydrogenase; Glucosephosphates; Glutathione; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hydrogen Peroxide; Intracellular Fluid; Lactates; Lactic Acid; NAD; NADP; Oxidation-Reduction; Oxidative Stress; Pentose Phosphate Pathway; Phosphofructokinase-1 | 1995 |
Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction.
Topics: Animals; Blood Flow Velocity; Blood Glucose; Capillary Permeability; Cattle; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosylation; Humans; Male; NAD; Nitric Oxide; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Serum Albumin; Serum Albumin, Bovine; Sorbitol; Superoxides | 1996 |
Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels.
Topics: Alkaloids; Animals; Capillary Permeability; Diabetic Angiopathies; Diglycerides; Glucose; Glycerides; Granulation Tissue; Male; Microcirculation; NAD; Protein Kinase C; Rats; Rats, Inbred Strains; Staurosporine; Tetradecanoylphorbol Acetate | 1991 |
Polyol pathway activity in aorta.
Topics: Animals; Aorta; Arteriosclerosis; Diabetic Angiopathies; Fructose; Fructose-Bisphosphate Aldolase; Glucose; Hyperglycemia; NAD; Oxidoreductases; Oxygen Consumption; Rabbits; Sorbitol | 1973 |